Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MultiPhen Resource Report Resource Website 10+ mentions |
MultiPhen (RRID:SCR_003498) | software resource | Software package that performs genetic association tests between SNPs (one-at-a-time) and multiple phenotypes (separately or in joint model). | standalone software, r, bio.tools |
is listed by: OMICtools is listed by: Debian is listed by: bio.tools has parent organization: CRAN |
PMID:22567092 | GNU General Public License, v2 | biotools:multiphen, OMICS_04397 | https://bio.tools/multiphen | SCR_003498 | MultiPhen: a package for the genetic association testing of multiple phenotypes | 2026-02-14 02:00:34 | 29 | ||||||
|
EBSeq Resource Report Resource Website 500+ mentions |
EBSeq (RRID:SCR_003526) | EBSeq | software resource | Software R package for RNA-Seq Differential Expression Analysis. | bio.tools |
is listed by: OMICtools is listed by: Debian is listed by: bio.tools has parent organization: University of Wisconsin-Madison; Wisconsin; USA |
PMID:23428641 DOI:10.1093/bioinformatics/btt087 |
biotools:ebseq, OMICS_01307 | https://bio.tools/ebseq https://sources.debian.org/src/r-bioc-ebseq/ |
SCR_003526 | 2026-02-14 02:00:51 | 577 | |||||||
|
MetaSKAT Resource Report Resource Website 10+ mentions |
MetaSKAT (RRID:SCR_003489) | MetaSKAT | software resource | A R package for multiple marker meta-analysis. |
is listed by: OMICtools has parent organization: Harvard T.H. Chan School of Public Health |
PMID:23768515 | Free | OMICS_00241 | SCR_003489 | 2026-02-14 02:00:50 | 31 | ||||||||
|
Savant Resource Report Resource Website 50+ mentions |
Savant (RRID:SCR_003488) | Savant | software resource | Next-generation genome browser software designed for the latest generation of genome data. |
is listed by: OMICtools has parent organization: University of Toronto; Ontario; Canada |
Free, Available for download, Freely available | OMICS_00923 | https://github.com/compbio-UofT/savant | SCR_003488 | 2026-02-14 02:00:33 | 64 | ||||||||
|
jmzTab Resource Report Resource Website 1+ mentions |
jmzTab (RRID:SCR_003481) | software resource | A Java interface to the mzTab data exchange format for reporting a summary of proteomics results. | standalone software, mac os x, unix/linux, java, bio.tools |
is listed by: OMICtools is listed by: Debian is listed by: bio.tools has parent organization: Google Code |
PMID:24659499 | Apache License, v2 | OMICS_04542, biotools:jmztab | https://bio.tools/jmztab | SCR_003481 | 2026-02-14 02:00:50 | 1 | |||||||
|
Chung-Ang University; Seoul; South Korea Resource Report Resource Website |
Chung-Ang University; Seoul; South Korea (RRID:SCR_003547) | university | Private comprehensive research university in South Korea. Starting as a church-run kindergarten in 1918, CAU transformed into a school for female kindergarten teachers in 1922 and was granted university status in 1953. | grid.254224.7, ISNI:0000 0001 0789 9563, Crossref funder ID:501100002460, nlx_10442, Wikidata:Q41790 | https://ror.org/01r024a98 | SCR_003547 | CAU | 2026-02-14 02:00:28 | 0 | ||||||||||
|
MAGENTA Resource Report Resource Website 100+ mentions |
MAGENTA (RRID:SCR_003422) | MAGENTA | software resource | A computational tool that tests for enrichment of genetic associations in predefined biological processes or sets of functionally related genes, using genome-wide genetic data as input. |
is listed by: OMICtools has parent organization: Broad Institute |
PMID:20714348 | Free, Available for download, Freely available | OMICS_00236 | SCR_003422 | Meta-Analysis Gene-set Enrichment of variaNT Associations | 2026-02-14 02:00:27 | 140 | |||||||
|
NAPPA Resource Report Resource Website 10+ mentions |
NAPPA (RRID:SCR_003419) | NAPPA | software resource | Software that enables the processing and normalization of the standard mRNA data output from the Nanostring nCounter software. | normalization, processing, nanostring, mirna, mrna, os x, windows | is listed by: OMICtools | GNU General Public License, v3 | OMICS_02310 | SCR_003419 | NAPPA: Performs the processing and normalisation of Nanostring miRNA and mRNA data | 2026-02-14 02:00:48 | 12 | |||||||
|
FadE Resource Report Resource Website 10+ mentions |
FadE (RRID:SCR_003448) | FadE | software resource | A software package designed to determine the methylation parameter at each cytosine or cytosine-guanine position in the human genome. FadE uses color reads produced by the SOLiD sequencer or nucleotide reads produced by the Illumina or 454 sequencing platforms. |
is listed by: OMICtools has parent organization: Google Code has parent organization: University of Southern California; Los Angeles; USA |
PMID:22965123 | Free, Available for download, Freely available | OMICS_00599 | https://minituba.hegroup.org/ | SCR_003448 | fade - Estimation of position specific methylation parameters in color or nucleotide space with NR optimization | 2026-02-14 02:00:27 | 34 | ||||||
|
Proteome Commons Tranche repository Resource Report Resource Website 1+ mentions |
Proteome Commons Tranche repository (RRID:SCR_003441) | Tranche | software resource | A distributed file storage system that you can upload files to and download files from. All files uploaded to the repository are replicated several times to protect against their accidental loss. Files uploaded to the repository can be of any size, can be of any file type, and can be encrypted with a passphrase of your choosing. The Proteome Commons Tranche repository is the first instance of a Tranche repository. Tranche, was created so that anybody can take it and make their own Tranche repository. This is the first implementation of the Tranche software, and is useful as a test bed for the software. This repository relies on educational institutions to provide the hardware and facilities for Tranche servers. While we maintain a set of servers, the continued growth of this public resource will rely on the generosity of the institutions that use the repository most. | proteome, storage, proteomics, distributed, server, mass spectrometry, protein, peptide, file sharing, security |
is listed by: Biositemaps has parent organization: University of Michigan; Ann Arbor; USA has parent organization: Proteome Commons |
NCI ; Clinical Proteomics Technologies for Cancer ; NCRR P41-RR018627 |
PMID:21063945 PMID:20356086 |
Open unspecified license (Apache v2); registration required . See Terms of Use, Https://proteomecommons.org/terms.jsp | nif-0000-33195 | http://tranche.proteomecommons.org | SCR_003441 | Tranche Project | 2026-02-14 02:00:33 | 8 | ||||
|
metagen Resource Report Resource Website 10+ mentions |
metagen (RRID:SCR_003443) | metagen | software resource | Software program providing a method for meta-analysis of case-control genetic association studies using random-effects logistic regression. | bio.tools |
is listed by: OMICtools is listed by: Debian is listed by: bio.tools |
PMID:17605724 | Free, Available for download, Freely available | OMICS_00238, biotools:metagen | https://www.rdocumentation.org/packages/meta/versions/4.9-6/topics/metagen | SCR_003443 | 2026-02-14 02:00:27 | 18 | ||||||
|
Innovative Medicines Initiative Resource Report Resource Website 100+ mentions |
Innovative Medicines Initiative (RRID:SCR_003754) | IMI | organization | Initiative to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. It does this by initiating and managing consortia composed of the key players involved in healthcare research, including universities, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organizations, and medicines regulators. IMI is a public-private partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA), with a timeframe separated into two phases (2008-2013, 2014-2024) that are each defined by unique research agendas. The first phase (2008 2013) had four pillars that defined the focus of its research agenda: * Predicting safety: evaluating the safety of a compound during the pre-clinical phase of the development process and the later phases in clinical development. * Predicting efficacy: improving the ability to predict how a drug will interact in humans and how it may produce a change in function. * Knowledge management: utilization of information and data for predicting safety and efficacy. * Education and training: closing existing training gaps in the drug development process. Some of the consortia managed under IMI focused on specific health issues while others focused on broader challenges in drug development. Additionally, IMI launched a number of education and training projects during its first phases. The goal of the second phase (IMI2, 2014-2024) is to develop next generation vaccines and drugs. The focus is on delivering the right prevention and treatment for the right patient at the right time. There is a strong focus on the development of new medicines with an emphasis on tools and methods that accelerate patient access to new medicines. IMI2's agenda can be defined by four axes of research: * target validation and biomarker research (efficacy and safety) * adoption of innovative clinical trial paradigms * innovative medicines * patient-tailored adherence programs As part of its distinct goals, IMI2 aims to deliver: * 30% better success rate in clinical trials of priority medicines identified by the WHO; clinical proof of concept in immunological, respiratory, neurological and neurodegenerative diseases in five years; * new and approved diagnostic markers for four of these diseases and at least two new medicines which could either be new antibiotics or new therapies for Alzheimer's disease. | drug development, drug, tool development, biomarker, data sharing, target validation, safety, efficacy, clinical trial, medicine, adherence program, vaccine, consortium, diagnostic marker, oncology, drug discovery |
is listed by: Consortia-pedia is related to: AddNeuroMed is related to: European Federation of Pharmaceutical Industries and Associations has parent organization: European Union has parent organization: European Federation of Pharmaceutical Industries and Associations is parent organization of: AddNeuroMed |
European Union FP7 ; Horizon 2020 ; EFPIA ; Other life science industries or organizations |
Wikidata: Q1664196, nlx_157984, grid.454814.8, ISNI: 0000 0004 0577 0821 | https://ror.org/019af4n30 | SCR_003754 | 2026-02-14 02:00:52 | 275 | |||||||
|
Global Health Innovative Technology Fund Resource Report Resource Website 10+ mentions |
Global Health Innovative Technology Fund (RRID:SCR_003753) | GHIT Fund, GHIT | institution | A consortium that focuses their efforts on discovering and developing new pharmaceutical drugs, vaccines (both preventive and therapeutic) and diagnostics against the infectious diseases that are prevalent in developing countries. The initial targets are those disorders designated by WHO as neglected tropical diseases prevalent in developing nations. The consortium aims to facilitate international partnerships that enable Japanese technology, innovations, and insights to play a more direct role in improving global health. Another goal of GHIT is to develop a new drug-discovery screening platform to assist the screening of compound libraries housed within Japanese companies and academic institutions. The vision is to have Japanese research organizations donate compounds, with the Fund reimbursing screening costs and leveraging screening programs of existing product-development partners. | global health, health, drug development, biomarker, consortium, drug, vaccine, diagnostics, healthcare, developing country, disease | is listed by: Consortia-pedia | Government of Japan ; Bill and Melinda Gates Foundation ; Pharmaceutical industry |
grid.475132.6, nlx_157983 | https://ror.org/02yfqyv95 | SCR_003753 | 2026-02-14 02:00:35 | 16 | |||||||
|
Coca-Cola Company Resource Report Resource Website 1+ mentions |
Coca-Cola Company (RRID:SCR_003749) | Coca-Cola, KO | commercial organization | An American multinational beverage corporation and manufacturer, retailer and marketer of nonalcoholic beverage concentrates and syrups, which is headquartered in Atlanta, Georgia. (Wikipedia) It is the world's largest beverage company, refreshing consumers with more than 500 sparkling and still brands. | beverage | Crossref funder ID: 100004367, ISNI: 0000 0004 0504 2170, grid.451378.c, Wikidata: Q3295867, nlx_158091 | https://ror.org/00yc8qw13 | SCR_003749 | KO, The Coca-Cola Company, Coca-Cola | 2026-02-14 02:00:35 | 2 | ||||||||
|
Seven Hills Bioreagents Resource Report Resource Website 1+ mentions |
Seven Hills Bioreagents (RRID:SCR_003748) | commercial organization | An Antibody supplier | nlx_152458 | SCR_003748 | 2026-02-14 02:00:51 | 3 | ||||||||||||
|
RevMan Resource Report Resource Website 10000+ mentions |
RevMan (RRID:SCR_003581) | RevMan | software resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 5, 2023.A software package that does meta-analysis and provides results in tabular format and graphically., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. |
is listed by: OMICtools is listed by: SoftCite |
THIS RESOURCE IS NO LONGER IN SERVICE | OMICS_00244 | SCR_003581 | Review Manager | 2026-02-14 02:00:29 | 12961 | ||||||||
|
Torrey Pines Biolabs Resource Report Resource Website 100+ mentions |
Torrey Pines Biolabs (RRID:SCR_003580) | commercial organization | An Antibody supplier | nlx_152481 | SCR_003580 | Torrey Pines Biolabs Inc., Torrey Pines Biolabs Inc | 2026-02-14 02:00:52 | 376 | |||||||||||
|
Charles Stark Draper Laboratory Resource Report Resource Website 1+ mentions |
Charles Stark Draper Laboratory (RRID:SCR_003736) | Draper | nonprofit organization | A not-for-profit research and development laboratory focused on the design, development, and deployment of advanced technological solutions for the nation's most challenging and important problems in security, space exploration, healthcare, and energy. Their expertise includes the areas of guidance, navigation, and control systems; fault-tolerant computing; advanced algorithms and software solutions; modeling and simulation; and MEMS and multichip module technology. With a strong commitment to delivering working solutions to their sponsors, they apply their expertise to a variety of domains, including autonomous air, land, sea, and space systems; information integration; distributed sensors and networks; precision-guided munitions; and biomedical engineering; chemical/biological defense; and energy system modeling and management. When appropriate for the needs of their sponsors, they will work with commercial partners to transition their technology to commercial production. | engineering, technology, research, defense, space, biomedical, energy, service |
is related to: Massachusetts Institute of Technology; Massachusetts; USA; is parent organization of: Center for Integration of Medicine and Innovative Technology |
Acknowledgement required, Non-commercial | grid.417533.7, Crossref funder ID: 100006353, nlx_157942, ISNI: 0000 0004 0634 6125, Wikidata: Q2876029 | https://ror.org/04378d909 | SCR_003736 | Draper Laboratory, The Charles Stark Draper Laboratory Inc | 2026-02-14 02:00:52 | 1 | ||||||
|
PyroBayes Resource Report Resource Website 1+ mentions |
PyroBayes (RRID:SCR_003757) | PyroBayes | software resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 6, 2023. A base caller for pyrosequences from the 454 Life Sciences sequencing machines. | is listed by: OMICtools | PMID:18193056 | THIS RESOURCE IS NO LONGER IN SERVICE | OMICS_01155 | SCR_003757 | 2026-02-14 02:00:35 | 3 | ||||||||
|
Oxford Nanopore Technologies Resource Report Resource Website 100+ mentions |
Oxford Nanopore Technologies (RRID:SCR_003756) | Oxford Nanopore | commercial organization | Commercial organization developing a disruptive, proprietary technology platform for the direct, electronic analysis of single molecules. The instruments GridION and MinION are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. Consequently, the platform has a broad range of potential applications, including scientific research, personalized medicine, crop science and security / defence. | nanopore technology, dna, rna, protein, small molecule, molecule, analysis, nanopore, nanopore sensing |
is related to: READNA is related to: Pychopper |
nlx_158233 | SCR_003756 | Oxford Nanopore Technologies Ltd | 2026-02-14 02:00:51 | 399 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
